T Michas
Overview
Explore the profile of T Michas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schulpis K, Karikas G, Georgala S, Michas T, Tsakiris S
Int J Dermatol
. 2001 Mar;
40(1):33-6.
PMID: 11277950
Background: The use of Isotretinoin (Iso) for cystic acne (CA) therapy includes marked side-effects such as dyslipidemia, increased liver enzymes, and reduction of biotinidase activity. Moreover, Homocysteine (Hcy), an amino...
2.
Georgala S, Schulpis K, Georgala C, Michas T
J Eur Acad Dermatol Venereol
. 2000 Jan;
13(3):205-9.
PMID: 10642057
Background: Patients with cystic acne (CA) on Isotretinoin (Iso) therapy might present muscular symptoms as side effect of the drug. Myalgia, weakness, hypotension are also some of the main characteristics...
3.
Schulpis K, Georgala S, Papakonstantinou E, Michas T
J Eur Acad Dermatol Venereol
. 1999 Nov;
13(1):24-7.
PMID: 10565626
Background: Patients with cystic acne (CA) frequently report feeling self conscious, anxiety and social isolation. Methods: Mood characteristics as well as self-esteem scores of 38 patients with CA were evaluated...
4.
Schulpis K, Georgala S, Papakonstantinou E, Michas T, Karikas G
Skin Pharmacol Appl Skin Physiol
. 1999 May;
12(1-2):28-33.
PMID: 10325581
Background: Among the reaction and effects of isotretinoin, mucocutaneous reactions, xerosis and erythema of the skin as well as elevation of liver enzymes and lipids except high density lipoprotein have...
5.
Karikas G, Schulpis K, Kokotos G, Michas T, Georgala S
Clin Biochem
. 1997 Jul;
30(5):439-42.
PMID: 9253522
No abstract available.
6.
Schulpis C, Antoniou C, Michas T, Strarigos J
Pediatr Dermatol
. 1989 Dec;
6(4):332-5.
PMID: 2616391
L-Phenylalanine is a promising agent for the treatment of vitiligo when taken orally and followed with ultraviolet light (UVA) irradiation. Of 13 children so treated, 3 experienced repigmentation of all...
7.
Antoniou C, Schulpis H, Michas T, Katsambas A, Frajis N, Tsagaraki S, et al.
Int J Dermatol
. 1989 Oct;
28(8):545-7.
PMID: 2583897
The administration of phenylalanine (Phe) combined with UVA exposure was found to be effective in treating vitiligo. Twenty-one patients with vitiligo were divided in two groups: eleven patients were treated...